CPC C07D 471/04 (2013.01) [A61K 31/437 (2013.01); A61K 31/519 (2013.01); A61P 25/28 (2018.01); C07D 487/04 (2013.01)] | 17 Claims |
1. A method of treating Alzheimer's disease, Huntington's disease, fronto-temporal lobar degeneration, Friedreich's ataxia, post-traumatic stress disorder, Parkinson's disease, Parkinson's disease dementia, substance dependence recovery, memory or cognitive function disorder or impairment, neurological disorder with synaptic pathology, disorder of learning distinction, psychiatric disorders, cognitive function or impairment associated with Alzheimer's disease, Lewy body dementia, schizophrenia, Rubinstein Taybi syndrome, Rett Syndrome, Fragile X, multiple sclerosis, age associated memory impairment, age related cognitive decline, and social, cognitive and learning disorders associated with autism in a subject in need thereof, comprising administering to the subject an effective amount of a compound having the Formula:
or a pharmaceutically acceptable salt thereof.
|